Skip to main navigation Skip to search Skip to main content

A cluster randomised controlled trial to test the effectiveness and cost-effectiveness of a self-management intervention to support women with breast cancer to return to work: A study protocol

  • Nickola D Pallin
  • , Naomi Algeo
  • , Mary Eileen O'Connor
  • , Hayley Connolly
  • , Michelle Lowry
  • , Kathleen Bennett
  • , Patrick Gillespie
  • , Anna Hobbins
  • , Pamela Gallagher
  • , Louise Mullen
  • , Kathleen D Lyons
  • , Sheena M McHugh
  • , Deirdre Connolly
    • Trinity College Dublin
    • RCSI University of Medicine and Health Sciences
    • J.E. Cairnes School of Business and Economics and the Institute for Lifecourse and Society
    • CÚRAM- Research Ireland Centre for Medical Devices
    • Institute for Lifecourse and Society (ILAS)
    • Dublin City University
    • National Cancer Control Programme
    • MGH Institute of Health Professions
    • University College Cork

    Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

    Abstract

    INTRODUCTION: Women living with and beyond breast cancer (LWBBC) often experience challenges in returning to work (RTW) because of disease and treatment-related side effects. Therefore, interventions to enhance RTW for those LWBBC are a recommended component of cancer survivorship care. CanWork is a six-week, self-management support programme designed to facilitate women LWBBC in developing knowledge and skills to manage cancer-related symptoms that interfere with RTW. This paper presents the protocol for a cluster randomised controlled trial that will test the effectiveness and cost effectiveness of CanWork in supporting women LWBBC in RTW following completion of cancer treatment.

    METHODS: A cluster-randomised controlled trial will be conducted through community cancer support centres in the Republic of Ireland. Centres will be assigned to the control or intervention arms by randomisation and the aim is to recruit 248 women. The two primary outcomes are changes in RTW (yes: returned to work; no: not returned to work) and self-efficacy to manage physical, psychological and emotional demands of work at 12 months follow up post-intervention. Secondary outcomes are readiness to return to work, self-efficacy for managing cancer-related symptoms that interfere with work, health related quality of life and absence from work for cancer-related reasons at 12 months follow up post-intervention. Cost effectiveness will also be measured. Follow-up will occur up to 12-months post-intervention using self-reported questionnaires.

    DISCUSSION: Findings will determine whether CanWork is an effective and cost-effective intervention in supporting women with breast cancer to return to work.

    TRIAL REGISTRATION NUMBER: NCT06723899.

    Original languageEnglish
    Pages (from-to)108185
    JournalContemporary Clinical Trials
    Volume161
    DOIs
    Publication statusPublished - Feb 2026

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Humans
    • Female
    • Breast Neoplasms/psychology
    • Return to Work/psychology
    • Cost-Benefit Analysis
    • Self-Management/methods
    • Ireland
    • Self Efficacy
    • Cancer Survivors/psychology
    • Randomized Controlled Trials as Topic
    • Quality of Life
    • Adult

    Fingerprint

    Dive into the research topics of 'A cluster randomised controlled trial to test the effectiveness and cost-effectiveness of a self-management intervention to support women with breast cancer to return to work: A study protocol'. Together they form a unique fingerprint.

    Cite this